1 - 10 of 38 articles
This review of stereotactic ablative radiotherapy for spinal metastases contextualizes decisions about optimal multidisciplinary management to help clinicians provide personalized high-quality care for these patients.
Key PointsQuestionWhat is the optimal duration of oxaliplatin-based adjuvant chemotherapy with capecitabine plus oxaliplatin (CAPOX) or fluorouracil, leucovorin, and oxaliplatin (FOLFOX) for patients with high-risk stage II resected colorectal cancer?
FindingsIn this subgroup analysis of a...
This Viewpoint discusses limitations of preprints and how they may change oncology practice and research.
This secondary analysis of a randomized clinical trial examines the association between immune-related adverse events and recurrence-free survival among patients with high-risk stage III melanoma who were treated with pembrozimulab therapy or placebo in the EORTC 1325/KEYNOTE-054 study.
Key PointsQuestionHow did the entry of imatinib into the generic market change health plan spending and patient cost responsibility associated with imatinib and comparable second-line drugs for chronic myeloid leukemia (ie, nilotinib and dasatinib)?
FindingsIn this retrospective cohort study,...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.